M-NSG

1. Shear stress governs hematopoietic stem cell fate to promote inflammation-induced aging
发表年份：2026 来源杂志：Nature Aging

2. FOSL1 Orchestrates Epigenetic Reprogramming of Anaplastic Thyroid Cancer and Suppresses Natural Killer Cell-Mediated Antitumor Immunity
发表年份：2026 来源杂志：CANCER RESEARCH

3. Structure–Activity-Driven Multicompartment Lipid Nanoparticles for Synergistic mRNA and siRNA Codelivery in Acute Myeloid Leukemia
发表年份：2026 来源杂志：Journal of the American Chemical Society

4. Apoptotic bodies derived from human umbilical cord mesenchymal stem cells improve recovery from myocardial infarction in swine
发表年份：2026 来源杂志：Autophagy

5. ZBTB21 Is a Dual Suppressor of Pyroptosis and MHC-I Antigen Presentation That Promotes Tumor Immune Evasion
发表年份：2026 来源杂志：Advanced Science

6. PD-L1-Binding Antigen Presenters: Redirecting Vaccine-Induced Antibodies for Cancer Immunotherapy
发表年份：2026 来源杂志：Advanced Science

7. Vessels encapsulating tumor clusters promote non-invasive metastasis of hepatocellular carcinoma by shaping an immunosuppressive microenvironment
发表年份：2026 来源杂志：JOURNAL OF CLINICAL INVESTIGATION

8. Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors
发表年份：2026 来源杂志：Science Advances

9. mRNA lipid-nanoparticle-mediated mitochondrial apoptosis augments adoptive T cell immunotherapy
发表年份：2026 来源杂志：Cell Reports Medicine

10. Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy
发表年份：2026 来源杂志：Journal for ImmunoTherapy of Cancer

11. A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
发表年份：2026 来源杂志：Cell Reports Medicine

12. Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy
发表年份：2026 来源杂志：CANCER LETTERS

13. USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination
发表年份：2026 来源杂志：International Journal of Biological Sciences

14. Unleashing T cell surveillance for the eradication of quiescent persister tumor cells resistant to neoadjuvant chemotherapy
发表年份：2026 来源杂志：DEVELOPMENTAL CELL

15. A shark VNAR-IL-15 fusion protein that suppresses TROP2+ tumor growth
发表年份：2026 来源杂志：INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

16. Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling
发表年份：2026 来源杂志：Journal of Orthopaedic Translation

17. Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors
发表年份：2026 来源杂志：Cell Reports

18. Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
发表年份：2026 来源杂志：JOURNAL OF MEDICINAL CHEMISTRY

19. Halofuginone exerts broad-spectrum cytotoxic effects by regulating p-eIF2α-S100A8/A9-calcium signaling, inhibiting global protein synthesis, and reversing the resistance of idarubicin in acute myeloid leukemia
发表年份：2026 来源杂志：Chinese Medicine

20. Lycorine suppresses cell growth and attenuates stemness through PI3K/AKT pathway in ovarian cancer
发表年份：2026 来源杂志：BIOCHEMICAL PHARMACOLOGY

21. Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance
发表年份：2026 来源杂志：Cancer Drug Resistance

22. ERCC6L promotes cutaneous melanoma progression via PLK1-mediated aerobic glycolysis: Mechanisms and therapeutic implications
发表年份：2026 来源杂志：LIFE SCIENCES

23. A novel human acute myeloid leukemia cell line SDEY-AML1 with KMT2A: MLLT3, IKZF1: EVX1 fusions exhibits high tumorigenicity in NSG mice
发表年份：2026 来源杂志：Scientific Reports

24. Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety Profile
发表年份：2026 来源杂志：DRUGS IN R&D

25. Construction of a novel B7H3 VHH-Fc antibody with potent antitumor activity and NK/T cell activation
发表年份：2026 来源杂志：PROTEIN EXPRESSION AND PURIFICATION

26. Cytosolic acetyl-coenzyme A is a signalling metabolite to control mitophagy
发表年份：2025 来源杂志：NATURE

27. SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic target
发表年份：2025 来源杂志：Cellular & Molecular Immunology

28. TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
发表年份：2025 来源杂志：CANCER RESEARCH

29. MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer
发表年份：2025 来源杂志：CANCER RESEARCH

30. Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation
发表年份：2025 来源杂志：Nature Communications

31. USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination
发表年份：2025 来源杂志：Acta Pharmaceutica Sinica B

32. OX40–heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice
发表年份：2025 来源杂志：Science Translational Medicine

33. Prickle4 Drives Microenvironmental Remodeling and Resistance to Parp Inhibition in IDH-Mutant Glioma
发表年份：2025 来源杂志：Advanced Science

34. Chemotherapy-Mediated Induction of PD-L1 via SEI1 Facilitates Myeloma Immune Evasion
发表年份：2025 来源杂志：Advanced Science

35. DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR-JAK2-STAT3 Pathway
发表年份：2025 来源杂志：Advanced Science

36. SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma
发表年份：2025 来源杂志：Advanced Science

37. An Engineered Probiotic Consortium Based on Quorum-Sensing for Colorectal Cancer Immunotherapy
发表年份：2025 来源杂志：Advanced Science

38. SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells
发表年份：2025 来源杂志：LEUKEMIA

39. Liquid-liquid phase separation of ZHX2 protects DLBCL cells against ferroptosis through induction of SLC3A2
发表年份：2025 来源杂志：LEUKEMIA

40. STING mediates increased self-renewal and lineage skewing in DNMT3A-mutated hematopoietic stem/progenitor cells
发表年份：2025 来源杂志：LEUKEMIA

41. 5-FU@HFn combined with decitabine induces pyroptosis and enhances antitumor immunotherapy for chronic myeloid leukemia
发表年份：2025 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

42. Asparaginase Enhances CAR-T Cell Antitumor Immunity by Asparagine Metabolic Reprogramming and Induction of Central Memory Phenotype in ALL
发表年份：2025 来源杂志：MOLECULAR THERAPY

43. BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer
发表年份：2025 来源杂志：Journal for ImmunoTherapy of Cancer

44. JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer
发表年份：2025 来源杂志：Cell Death & Disease

45. Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5
发表年份：2025 来源杂志：Cell Death & Disease

46. UHRF1-mediated epigenetic reprogramming regulates glycolysis to promote progression of B-cell acute lymphoblastic leukemia
发表年份：2025 来源杂志：Cell Death & Disease

47. ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation
发表年份：2025 来源杂志：Cell Death & Disease

48. Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma
发表年份：2025 来源杂志：Cell Death & Disease

49. Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy
发表年份：2025 来源杂志：Biomaterials Research

50. Ephrin A1 functions as a ligand of EGFR to promote EMT and metastasis in gastric cancer
发表年份：2025 来源杂志：EMBO JOURNAL

51. Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model
发表年份：2025 来源杂志：Cell Communication and Signaling

52. Retinoic acid enhances γδ T cell cytotoxicity in nasopharyngeal carcinoma by reversing immune exhaustion
发表年份：2025 来源杂志：Cell Communication and Signaling

53. Histone acetylation activated-IGF2BP3 regulates cyclin D1 mRNA stability to drive cell cycle transition and tumor progression of hepatocellular carcinoma
发表年份：2025 来源杂志：INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

54. Deoxypodophyllotoxin inhibited the growth of malignant pleural mesothelioma by inducing necroptosis and mitotic catastrophe
发表年份：2025 来源杂志：PHYTOMEDICINE

55. CBX5 loss drives Pl3Kδ inhibitor resistance in mantle cell lymphoma and propolis restores sensitivity by inducing CBX5-mediated ferroptosis
发表年份：2025 来源杂志：PHYTOMEDICINE

56. Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma
发表年份：2025 来源杂志：npj Precision Oncology

57. Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer
发表年份：2025 来源杂志：NEOPLASIA

58. T cell receptor-like antibody specifically targets and eliminates cells infected with cytomegalovirus
发表年份：2025 来源杂志：Journal of Translational Medicine

59. Microenvironmental β-TrCP negates amino acid transport to trigger CD8+ T cell exhaustion in human non-small cell lung cancer
发表年份：2025 来源杂志：Cell Reports

60. LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy
发表年份：2025 来源杂志：ONCOGENE

61. KRT5high TP63-expressing urothelial basal cells act as a driver to bladder urothelium regeneration in rabbit
发表年份：2025 来源杂志：Stem Cell Research & Therapy

62. Metrnl protects intestinal barrier function by regulating tight junctions via the IKKβ/IκBα/NFκB/MLCK/MLC signaling pathway
发表年份：2025 来源杂志：Cell Death Discovery

63. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy
发表年份：2025 来源杂志：Cell Reports

64. ENPP1 governs the metabolic regulation of effector T cells in autoimmunity by detecting cytosolic mitochondrial DNA
发表年份：2025 来源杂志：Cell Reports

65. Discovery of P11–2: A Potent First-in-Class MNK1-Targeting PROTAC Degrader for the Treatment of Cancer
发表年份：2025 来源杂志：JOURNAL OF MEDICINAL CHEMISTRY

66. Deciphering the role of IGF2BP2 and PRMT5 in gallbladder cancer progression: insights from multi-omics analysis
发表年份：2025 来源杂志：BRITISH JOURNAL OF CANCER

67. The pronounced cytotoxic effects of chimeric antigen receptor T cells targeting B7-H3 in organoids and liver xenografts derived from colorectal cancer patients
发表年份：2025 来源杂志：BRITISH JOURNAL OF CANCER

68. Tumor-derived CD84 promotes growth of acute myeloid leukemia cells via regulating non-homologous DNA end joining pathway
发表年份：2025 来源杂志：MOLECULES AND CELLS

69. Coke Oven Emission Exposure Triggers Malignant Transformation of Lung Epithelial Cells by SFTA1P-Dependent Alteration of Acetyl-CoA Metabolism
发表年份：2025 来源杂志：Environment & Health

70. Targeted editing of CCL5 with CRISPR-Cas9 nanoparticles enhances breast cancer immunotherapy
发表年份：2025 来源杂志：APOPTOSIS

71. COL4A2 drives ECM remodeling and stiffness increasing to promote breast cancer metastasis via YAP signaling pathway in dECM induced models
发表年份：2025 来源杂志：Biomaterials Advances

72. Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways
发表年份：2025 来源杂志：Cancer Cell International

73. Chemical induction of ferroptosis through GPX4 inhibition: Rational Design of Triazole-Benzoxazine Hybrids for melanoma therapy
发表年份：2025 来源杂志：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

74. Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer
发表年份：2025 来源杂志：Frontiers in Immunology

75. High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer
发表年份：2025 来源杂志：Frontiers in Immunology

76. Scalable Matrigel-Free Suspension Culture for Generating High-Quality Human Liver Ductal Organoids
发表年份：2025 来源杂志：CELL PROLIFERATION

77. Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
发表年份：2025 来源杂志：MOLECULAR CANCER THERAPEUTICS

78. Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy
发表年份：2025 来源杂志：MOLECULAR CANCER THERAPEUTICS

79. Targeting CHEK1: Ginsenosides-Rh2 and Cu2O@G-Rh2 nanoparticles in thyroid cancer
发表年份：2025 来源杂志：CELL BIOLOGY AND TOXICOLOGY

80. Targeted delivery of circPDHK1 siRNA via aptamer functionalized lipid nanoparticles inhibits ccRCC growth and migration
发表年份：2025 来源杂志：INTERNATIONAL JOURNAL OF PHARMACEUTICS

81. mRNA-laden lipid nanoparticle-enabled humanized CD19 CAR-T-cell engineering for the eradication of leukaemic cells
发表年份：2025 来源杂志：BRITISH JOURNAL OF HAEMATOLOGY

82. In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China
发表年份：2025 来源杂志：Frontiers in Cellular and Infection Microbiology

83. Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells
发表年份：2025 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

84. ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
发表年份：2025 来源杂志：Frontiers in Pharmacology

85. NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia
发表年份：2025 来源杂志：CANCER BIOLOGY & THERAPY

86. Motor neuron and pancreas homeobox 1 (MNX1) suppresses Triple Negative Breast Cancer (TNBC) cell phagocytosis by macrophage through CD24 signaling
发表年份：2025 来源杂志：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

87. CD9 antibody enhances the anti-leukemia efficacy of γδT cells in adult B cell acute lymphoblastic leukemia
发表年份：2025 来源杂志：iScience

88. Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis
发表年份：2025 来源杂志：Translational Cancer Research

89. Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy
发表年份：2025 来源杂志：Signal Transduction and Targeted Therapy

90. A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer
发表年份：2025 来源杂志：Nature Nanotechnology

91. CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA
发表年份：2025 来源杂志：Molecular Cancer

92. Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
发表年份：2025 来源杂志：Cell Metabolism

93. Arachidonic acid triggers spermidine synthase secretion from primary tumor to induce skeletal muscle weakness upon irradiation
发表年份：2025 来源杂志：Cell Metabolism

94. Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
发表年份：2025 来源杂志：Nature Biomedical Engineering

95. Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance
发表年份：2025 来源杂志：IMMUNITY

96. Clinical functional proteomics of intercellular signalling in pancreatic cancer
发表年份：2024 来源杂志：NATURE

97. Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
发表年份：2024 来源杂志：CANCER CELL

98. Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
发表年份：2024 来源杂志：NATURE MATERIALS

99. An oncolytic virus–T cell chimera for cancer immunotherapy
发表年份：2024 来源杂志：NATURE BIOTECHNOLOGY

100. The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
发表年份：2024 来源杂志：Cancer Discovery

101. Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
发表年份：2024 来源杂志：Cell Metabolism

102. Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
发表年份：2024 来源杂志：Cell Metabolism

103. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway
发表年份：2024 来源杂志：Molecular Cancer

104. Photo-metallo-immunotherapy: Fabricating Chromium-Based Nanocomposites to Enhance CAR-T Cell Infiltration and Cytotoxicity against Solid Tumors
发表年份：2024 来源杂志：ADVANCED MATERIALS

105. An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity
发表年份：2024 来源杂志：ADVANCED MATERIALS

106. Enhanced engraftment of human haematopoietic stem cells via mechanical remodelling mediated by the corticotropin-releasing hormone
发表年份：2024 来源杂志：Nature Biomedical Engineering

107. Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice
发表年份：2024 来源杂志：Cell Stem Cell

108. FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity
发表年份：2024 来源杂志：Nature Communications

109. Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors
发表年份：2024 来源杂志：Nature Communications

110. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
发表年份：2024 来源杂志：Nature Communications

111. Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy
发表年份：2024 来源杂志：Nature Communications

112. Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice
发表年份：2024 来源杂志：Nature Communications

113. Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity
发表年份：2024 来源杂志：Nature Communications

114. Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation
发表年份：2024 来源杂志：Nature Communications

115. Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies
发表年份：2024 来源杂志：Nature Communications

116. ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms
发表年份：2024 来源杂志：Autophagy

117. Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT-PD-L1 Axis
发表年份：2024 来源杂志：Advanced Science

118. Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development
发表年份：2024 来源杂志：Advanced Science

119. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer
发表年份：2024 来源杂志：Advanced Science

120. SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil Extracellular Trap Formation via the NFATc1/CXCL8 Axis
发表年份：2024 来源杂志：Advanced Science

121. A pan-KRAS degrader for the treatment of KRAS-mutant cancers
发表年份：2024 来源杂志：Cell Discovery

122. ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis
发表年份：2024 来源杂志：LEUKEMIA

123. Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia
发表年份：2024 来源杂志：LEUKEMIA

124. Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib
发表年份：2024 来源杂志：CANCER RESEARCH

125. Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma
发表年份：2024 来源杂志：CANCER RESEARCH

126. Adhesion GPCR ADGRE2 Maintains Proteostasis to Promote Progression in Acute Myeloid Leukemia
发表年份：2024 来源杂志：CANCER RESEARCH

127. PRDM16 Induces Methylation of FLT3 to Promote FLT3-ITD Signaling and Leukemia Progression
发表年份：2024 来源杂志：CANCER RESEARCH

128. HDAC6-dependent deacetylation of NGF dictates its ubiquitination and maintains primordial follicle dormancy
发表年份：2024 来源杂志：Theranostics

129. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease
发表年份：2024 来源杂志：Gut Microbes

130. Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
发表年份：2024 来源杂志：Cell Reports Medicine

131. Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

132. Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia
发表年份：2024 来源杂志：Journal of Advanced Research

133. Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies
发表年份：2024 来源杂志：Journal of Advanced Research

134. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

135. LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

136. USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

137. iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation
发表年份：2024 来源杂志：MedComm

138. Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
发表年份：2024 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

139. RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

140. ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

141. ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

142. Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

143. Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways
发表年份：2024 来源杂志：EMBO JOURNAL

144. Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia
发表年份：2024 来源杂志：Cell Communication and Signaling

145. KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
发表年份：2024 来源杂志：International Journal of Biological Sciences

146. The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment
发表年份：2024 来源杂志：Cell Death & Disease

147. A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells
发表年份：2024 来源杂志：Cell Death & Disease

148. EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification
发表年份：2024 来源杂志：JOURNAL OF AUTOIMMUNITY

149. Connexin 25 maintains self-renewal and functions of airway basal cells for airway regeneration
发表年份：2024 来源杂志：Stem Cell Research & Therapy

150. Human umbilical cord mesenchymal stem cell-based gene therapy for hemophilia B using scAAV-DJ/8-LP1-hFIXco transduction
发表年份：2024 来源杂志：Stem Cell Research & Therapy

151. Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer
发表年份：2024 来源杂志：BIOMEDICINE & PHARMACOTHERAPY

152. IGSF9 promotes tumor invasion and metastasis through GSK-3β/β-catenin mediated EMT in lung cancer
发表年份：2024 来源杂志：NEOPLASIA

153. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway
发表年份：2024 来源杂志：Journal of Translational Medicine

154. IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
发表年份：2024 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

155. Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC
发表年份：2024 来源杂志：CANCER GENE THERAPY

156. ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer
发表年份：2024 来源杂志：Translational Oncology

157. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS
发表年份：2024 来源杂志：EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

158. Single-cell RNA-sequencing reveals a profound immune cell response in human cytomegalovirus-infected humanized mice
发表年份：2024 来源杂志：VIROLOGICA SINICA

159. Generation of self-renewing neuromesodermal progenitors with neuronal and skeletal muscle bipotential from human embryonic stem cells
发表年份：2024 来源杂志：Cell Reports Methods

160. PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles
发表年份：2024 来源杂志：SCANDINAVIAN JOURNAL OF IMMUNOLOGY

161. Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer
发表年份：2024 来源杂志：Biomedicines

162. Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity
发表年份：2024 来源杂志：ACS Omega

163. FYB1-targeted modulation of CAPG promotes AML progression
发表年份：2024 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

164. The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia
发表年份：2024 来源杂志：ANNALS OF HEMATOLOGY

165. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
发表年份：2024 来源杂志：DNA AND CELL BIOLOGY

166. Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice
发表年份：2024 来源杂志：Journal of Gastrointestinal Oncology

167. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing
发表年份：2024 来源杂志：MOLECULAR THERAPY

168. Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification
发表年份：2024 来源杂志：PHARMACOLOGICAL RESEARCH

169. miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair
发表年份：2024 来源杂志：JACC-Basic to Translational Science

170. Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis
发表年份：2024 来源杂志：International Journal of Biological Sciences

171. LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
发表年份：2024 来源杂志：Cell Death & Disease

172. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
发表年份：2024 来源杂志：Cell Death & Disease

173. Small extracellular vesicle piR-hsa-30937 derived from pancreatic neuroendocrine neoplasms upregulates CD276 in macrophages to promote immune evasion
发表年份：2024 来源杂志：Cancer Immunology Research

174. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome
发表年份：2024 来源杂志：Cell Reports

175. Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation
发表年份：2024 来源杂志：Stem Cell Research & Therapy

176. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation
发表年份：2024 来源杂志：PHYTOMEDICINE

177. Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer
发表年份：2024 来源杂志：OncoImmunology

178. PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
发表年份：2024 来源杂志：Frontiers in Immunology

179. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib
发表年份：2024 来源杂志：BIOCHEMICAL PHARMACOLOGY

180. The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML
发表年份：2024 来源杂志：MOLECULAR CANCER THERAPEUTICS

181. TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas
发表年份：2024 来源杂志：LIFE SCIENCES

182. FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis
发表年份：2024 来源杂志：Communications Biology

183. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer
发表年份：2024 来源杂志：INTERNATIONAL JOURNAL OF ONCOLOGY

184. Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
发表年份：2024 来源杂志：EJNMMI Radiopharmacy and Chemistry

185. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
发表年份：2024 来源杂志：DNA AND CELL BIOLOGY

186. Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023-03-18 来源杂志：Molecular Cancer

187. A novel antidiuretic hormone governs tumour-induced renal dysfunction
发表年份：2023 来源杂志：NATURE

188. Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals
发表年份：2023 来源杂志：CELL

189. Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia
发表年份：2023 来源杂志：Signal Transduction and Targeted Therapy

190. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023 来源杂志：Molecular Cancer

191. Tumors evade immune cytotoxicity by altering the surface topology of NK cells
发表年份：2023 来源杂志：NATURE IMMUNOLOGY

192. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress
发表年份：2023 来源杂志：GASTROENTEROLOGY

193. Bone marrow immune cells respond to fluctuating nutritional stress to constrain weight regain
发表年份：2023 来源杂志：Cell Metabolism

194. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
发表年份：2023 来源杂志：Cellular & Molecular Immunology

195. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2
发表年份：2023 来源杂志：NATURE CELL BIOLOGY

196. Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells
发表年份：2023 来源杂志：Nature Communications

197. SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity
发表年份：2023 来源杂志：Nature Communications

198. Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia
发表年份：2023 来源杂志：Nature Communications

199. Sequence-based drug design as a concept in computational drug design
发表年份：2023 来源杂志：Nature Communications

200. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models
发表年份：2023 来源杂志：Nature Communications

201. Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors
发表年份：2023 来源杂志：Cancer Communications

202. Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
发表年份：2023 来源杂志：Cancer Communications

203. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
发表年份：2023 来源杂志：JOURNAL OF CLINICAL INVESTIGATION

204. Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s
发表年份：2023 来源杂志：JOURNAL OF EXPERIMENTAL MEDICINE

205. CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune Escape
发表年份：2023 来源杂志：Advanced Science

206. NIRF/PET imaging of γδ T cells via metabolic glycoengineering and bioorthogonal labeling
发表年份：2023 来源杂志：CHEMICAL ENGINEERING JOURNAL

207. Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq
发表年份：2023 来源杂志：Advanced Science

208. Targeted therapy of central nervous system acute lymphoblastic leukemia with an integrin α6-targeted self-assembling proapoptotic nanopeptide
发表年份：2023 来源杂志：Engineering

209. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
发表年份：2023 来源杂志：Gut Microbes

210. Transcription factor Nkx2-3 maintains the self-renewal of hematopoietic stem cells by regulating mitophagy
发表年份：2023 来源杂志：LEUKEMIA

211. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
发表年份：2023 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

212. Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy
发表年份：2023 来源杂志：CANCER RESEARCH

213. PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
发表年份：2023 来源杂志：CANCER RESEARCH

214. Faecalibacterium prausnitzii abrogates intestinal toxicity and promotes tumor immunity to increase the efficacy of dual CTLA-4 and PD-1 checkpoint blockade
发表年份：2023 来源杂志：CANCER RESEARCH

215. Targeted glycan degradation potentiates cellular immunotherapy for solid tumors
发表年份：2023 来源杂志：PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

216. Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
发表年份：2023 来源杂志：Biomarker Research

217. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
发表年份：2023 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

218. DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response
发表年份：2023 来源杂志：HAEMATOLOGICA

219. Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
发表年份：2023 来源杂志：CANCER LETTERS

220. Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia
发表年份：2023 来源杂志：PHARMACOLOGICAL RESEARCH

221. PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma
发表年份：2023 来源杂志：BMC Medicine

222. Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia
发表年份：2023 来源杂志：INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

223. TGF-β blocking combined with photothermal therapy promote tumor targeted migration and long-term antitumor activity of CAR-T cells
发表年份：2023 来源杂志：Materials Today Bio

224. Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
发表年份：2023 来源杂志：ACTA PHARMACOLOGICA SINICA

225. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
发表年份：2023 来源杂志：Stem Cell Research & Therapy

226. Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
发表年份：2023 来源杂志：Frontiers in Immunology

227. SIGLEC10+ macrophages drive gastric cancer progression by suppressing CD8+ T cell function
发表年份：2023 来源杂志：CANCER IMMUNOLOGY IMMUNOTHERAPY

228. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma
发表年份：2023 来源杂志：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

229. CCL17 acts as an antitumor chemokine in micromilieu‐driven immune skewing
发表年份：2023 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

230. Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo
发表年份：2023 来源杂志：VIROLOGICA SINICA

231. Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma
发表年份：2023 来源杂志：CYTOTHERAPY

232. A second-generation CD38-CAR-T cell for the treatment of multiple myeloma
发表年份：2023 来源杂志：Cancer Medicine

233. Oxymatrine boosts hematopoietic regeneration by modulating MAPK/ERK phosphorylation after irradiation-induced hematopoietic injury
发表年份：2023 来源杂志：EXPERIMENTAL CELL RESEARCH

234. PD-L1 ImmunoPET on the basis of Avidin/Biotin pre-targeted cancer imaging
发表年份：2023 来源杂志：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

235. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份：2022-07-26 来源杂志：nature communications

236. A Chimeric Conjugate of Antibody and Programmable DNA Nanoassembly Smartly Activates T cell for Precise Cancer Cell Targeting
发表年份：2022-06-24 来源杂志：A Journal of the Gesellschaft Deutscher Chemiker

237. BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma
发表年份：2022 来源杂志：ADVANCED MATERIALS

238. Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy
发表年份：2022 来源杂志：Nature Biomedical Engineering

239. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份：2022 来源杂志：Nature Communications

240. Malfunction of airway basal stem cells plays a crucial role in pathophysiology of tracheobronchopathia osteoplastica
发表年份：2022 来源杂志：Nature Communications

241. Modeling Human Thyroid Development by Fetal Tissue-Derived Organoid Culture
发表年份：2022 来源杂志：Advanced Science

242. Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways
发表年份：2022 来源杂志：Advanced Science

243. Nano-Biohybrid DNA Engager That Reprograms the T-Cell Receptor
发表年份：2022 来源杂志：Journal of the American Chemical Society

244. Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer
发表年份：2022 来源杂志：Science Advances

245. Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in NPM1-mutated acute myeloid leukemia
发表年份：2022 来源杂志：Acta Pharmaceutica Sinica B

246. An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
发表年份：2022 来源杂志：MOLECULAR THERAPY

247. Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction
发表年份：2022 来源杂志：LEUKEMIA

248. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer
发表年份：2022 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

249. Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL
发表年份：2022 来源杂志：CELL DEATH AND DIFFERENTIATION

250. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
发表年份：2022 来源杂志：EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

251. Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2
发表年份：2022 来源杂志：Cell Reports

252. Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations
发表年份：2022 来源杂志：Cell Reports

253. Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
发表年份：2022 来源杂志：Cell Death & Disease

254. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma
发表年份：2022 来源杂志：Cell Death & Disease

255. LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway
发表年份：2022 来源杂志：CELL PROLIFERATION

256. Gene therapy with B-cell maturation antigen/CD3 bispecific antibody encoding plasmid DNA for treating multiple myeloma
发表年份：2022 来源杂志：BRITISH JOURNAL OF HAEMATOLOGY

257. Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor Cells
发表年份：2022 来源杂志：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

258. SLC35B4 Stabilizes c-MYC Protein by O-GlcNAcylation in HCC
发表年份：2022 来源杂志：Frontiers in Pharmacology

259. Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
发表年份：2022 来源杂志：Frontiers in Pharmacology

260. Large-cohort humanized NPI mice reconstituted with CD34+ hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy
发表年份：2022 来源杂志：FASEB JOURNAL

261. Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response
发表年份：2022 来源杂志：Frontiers in Oncology

262. ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma
发表年份：2022 来源杂志：Frontiers in Oncology

263. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer
发表年份：2022 来源杂志：Cancer Medicine

264. Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop
发表年份：2021 来源杂志：SCIENCE

265. A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
发表年份：2021 来源杂志：Science Translational Medicine

266. The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability
发表年份：2021 来源杂志：MOLECULAR CELL

267. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase
发表年份：2021 来源杂志：HEPATOLOGY

268. DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression
发表年份：2021 来源杂志：CANCER RESEARCH

269. Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
发表年份：2021 来源杂志：CLINICAL CANCER RESEARCH

270. WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
发表年份：2021 来源杂志：Acta Pharmaceutica Sinica B

271. TIGIT-Fc Promotes Antitumor Immunity
发表年份：2021 来源杂志：Cancer Immunology Research

272. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53
发表年份：2021 来源杂志：ONCOGENE

273. Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
发表年份：2021 来源杂志：Frontiers in Immunology

274. Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cells
发表年份：2021 来源杂志：Stem Cell Research & Therapy

275. Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection
发表年份：2021 来源杂志：Molecular Therapy-Methods & Clinical Development

276. Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
发表年份：2021 来源杂志：Cancers

277. A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms
发表年份：2021 来源杂志：ACTA PHARMACOLOGICA SINICA

278. Establishment of Functional Liver Spheroids From Human Hepatocyte-Derived Liver Progenitor-Like Cells for Cell Therapy
发表年份：2021 来源杂志：Frontiers in Bioengineering and Biotechnology

279. Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
发表年份：2021 来源杂志：Frontiers in Pharmacology

280. RXR Negatively Regulates Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem and Progenitor Cells
发表年份：2021 来源杂志：Stem Cell Reviews and Reports

281. Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1α pathway
发表年份：2021 来源杂志：PHYTOMEDICINE

282. CoFe2O4-Quantum Dots for Synergistic Photothermal/Photodynamic Therapy of Non-small-Cell Lung Cancer Via Triggering Apoptosis by Regulating PI3K/AKT Pathway
发表年份：2021 来源杂志：Nanoscale Research Letters

283. NGF nanoparticles enhance the potency of transplanted human umbilical cord mesenchymal stem cells for myocardial repair
发表年份：2021 来源杂志：AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

284. Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China
发表年份：2021 来源杂志：Annals of Translational Medicine

285. Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics
发表年份：2020 来源杂志：CELL

286. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation
发表年份：2020 来源杂志：Nature Communications

287. Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins
发表年份：2020 来源杂志：STEM CELLS

288. 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
发表年份：2020 来源杂志：Frontiers in Immunology

289. Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
发表年份：2020 来源杂志：Frontiers in Oncology

290. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation
发表年份：2020 来源杂志：Aging-US

291. Lgr5 maintains stemness and regulates cell property in nasopharyngeal carcinoma through Wnt/β-catenin signaling pathway
发表年份：2020 来源杂志：Stem Cell Research

292. Peptide Self-Assembly Nanoparticles Loaded with Panobinostat to Activate Latent Human Immunodeficiency Virus
发表年份：2019-05-01 来源杂志：J Biomed Nanotechnol